Impact of Asthma Treatments on Daily Activities
Information source: Ovation Research Group
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Asthma; Allergies
Phase: N/A
Status: Recruiting
Sponsored by: Ovation Research Group Official(s) and/or principal investigator(s):
Susan D Mathias, MPH, Principal Investigator, Affiliation: Ovation Research Group
Overall contact:
Nita Ngo, MPH, Phone: 888.631.9167, Email: asthmastudy@ovation.org
Summary
The primary objective of this web-based, cross-sectional study is to assess and compare the
ability to sleep, work or go to school, and to participate in leisure activities among
subjects who are receiving Xolair treatment and subjects who were eligible to receive
Xolair, but instead have been using Advair for at least 1 year.
Clinical Details
Official title: Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)
Study design: Cross-Sectional, Defined Population, Retrospective Study
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Have asthma and allergies
- Currently taking Xolair® or Advair®
- Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair®
for at least 12 months
- Between 18 and 55 years of age
- A non-smoker for at least 6 months
- Have internet access
Locations and Contacts
Nita Ngo, MPH, Phone: 888.631.9167, Email: asthmastudy@ovation.org
Ovation Research Group, San Francisco, California 94105, United States; Recruiting
Susan D Mathias, MPH, Principal Investigator
Additional Information
Starting date: June 2006
Last updated: July 5, 2006
|
